Document:

terminationag_desjourdy.htm

    TERMINATION
OF

    AMENDED AND RESTATED
EMPLOYMENT AGREEMENT

    

    This Termination, dated as of the
16th
day of May, 2008, of the Amended and Restated Employment Agreement dated as of
January 3, 2006, as amended on February 7, 2008 (the “Agreement”), by and
between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its
principal place of business at 37 Loring Drive, Framingham, MA  01702
(the "Company"), and Paul C. Desjourdy, residing at 25 Eastmount Road, Medfield,
MA  02052 (the "Employee").  Capitalized terms used but not
defined herein shall have the meaning as defined in the
Agreement.  Except as amended below, all terms and conditions of the
Agreement shall remain in full force and effect.

    

    In consideration of the mutual promises
contained in this Termination, the parties agree as follows:

    

    1.  Section 2 of the
Agreement shall be modified such that the term of the Agreement shall be limited
to June 30, 2008.

    

    2.  Section 8 shall have no
force and effect upon the termination of the Agreement.  As partial
incentive for executing this Termination, the Employee shall receive health and
dental insurance substantially similar to that which the Employee was receiving
immediately prior to the termination of his employment until the earlier of: (a)
June 30, 2009 or (b) the date the Employee is covered by substantially similar
insurance.

    

    3.  As additional incentive
to execute this Termination, the 900,000 restricted shares of Class A Common
Stock granted to the Employee on February 7, 2008 shall become fully vested,
without any further restrictions, as of the date of this
Termination.

    

    4.    Starting July
1, 2008, the Employee shall be hired as President, Chief Executive Officer,
Treasurer, General Counsel and Chief Financial Officer of the Company at a
monthly rate of $18,000 per month.  Such employment shall run month to
month until terminated by either party upon 30 day advance written
notice.

    

    IN WITNESS WHEREOF, the parties have
caused this Termination to be executed as of the date and year first above
written.

    

    SYMBOLLON PHARMACEUTICALS,
INC.

    

    

    By: /s/ Jack H.
Kessler______________

    Jack H. Kessler

    Chairman of the Board

    

    

    /s/ Paul C.
Desjourdy_______________

    Paul C. Desjourdyterminationag_kessler.htm

    TERMINATION
OF

    AMENDED AND RESTATED
EMPLOYMENT AGREEMENT

    

    This Termination, dated as of the
16th
day of May, 2008, of the Amended and Restated Employment Agreement dated as of
January 3, 2006, as amended on February 7, 2008 (the “Agreement”), by and
between Symbollon Pharmaceuticals, Inc., a Delaware corporation with its
principal place of business at 37 Loring Drive, Framingham, MA  01702
(the "Company"), and Jack H. Kessler, residing at 56 Presidential Drive,
Southborough, MA  01772 (the "Employee").  Capitalized terms
used but not defined herein shall have the meaning as defined in the
Agreement.  Except as amended below, all terms and conditions of the
Agreement shall remain in full force and effect.

    

    In consideration of the mutual promises
contained in this Termination, the parties agree as follows:

    

    1.  Section 2 of the
Agreement shall be modified such that the term of the Agreement shall be limited
to June 30, 2008.

    

    2.  Section 8 shall have no
force and effect upon the termination of the Agreement.  As partial
incentive for executing this Termination, the Employee shall receive health and
dental insurance substantially similar to that which the Employee was receiving
immediately prior to the termination of his employment until the earlier of: (a)
June 30, 2009 or (b) the date the Employee is covered by substantially similar
insurance.

    

    3.  As additional incentive
to execute this Termination, the 375,000 restricted shares of Class A Common
Stock granted to the Employee on February 7, 2008 shall become fully vested,
without any further restrictions, as of the date of this
Termination.

    

    IN WITNESS WHEREOF, the parties have
caused this Termination to be executed as of the date and year first above
written.

    

    SYMBOLLON PHARMACEUTICALS,
INC.

    

    

    By: /s/ Paul C.
Desjourdy____________

    Paul C. Desjourdy

    President/CEO

    

    

    /s/ Jack H.
Kessler_________________

    Jack H. Kessler

    
      
        
          
            	
                    1ex10-1.htm

    EXHIBIT
10.1

     

    AMENDMENT

    OF

    AMENDED
AND RESTATED

    ACCO
BRANDS CORPORATION

    2005
INCENTIVE PLAN

     

    This
Amendment (“Amendment”)
of the Amended and Restated ACCO Brands Corporation 2005 Incentive Plan (“Plan”)
is adopted effective February 28, 2008, subject to approval by a majority of the
voting stockholders at the first annual meeting of stockholders occurring after
the date hereof.

     

    1.           The
first sentence of Section 4(a) of the Plan is deleted in its entirety and
replaced as follows:

     

    “(a)  The
total number of shares of Common Stock that may be issued pursuant to Awards
made under the Plan, including Incentive Stock Options, is 6,703,000 shares
(including shares authorized under the Plan prior to the Effective
Date).”

     

    2.           Section
7(d)(i) of the Plan is deleted in its entirety and replaced as
follows:

    
       

      
        
          	
                   
      

                	
                  “(i)

                	
                  Subject
      to the provisions of the Plan and the applicable Restricted Stock Award,
      during the period established by the Committee commencing on the date of
      such Award and ending on the date that all restrictions under the Award
      lapse (the “Restriction
      Period”), the Participant shall not be permitted to sell, assign,
      transfer, pledge or otherwise encumber such shares of Restricted
      Stock.  Upon the lapse of the Restriction Period with respect to
      any Restricted Stock without a forfeiture thereof (in whole or in part),
      ACCO’s transfer agent will be notified that the transfer of such
      Restricted Stock shall no longer be subject to the terms, conditions and
      restrictions under the Award.  For the purpose of an Award of
      Restricted Stock Units, the “Restriction
      Period” shall be the period commencing on the date of the Award and
      ending on the date that the Award Participant satisfies all terms and
      conditions for which the Award becomes nonforfeitable (in whole or in
      part).  Notwithstanding the foregoing, the Restriction Period
      for Awards of Restricted Stock and Restricted Stock Units shall be for a
      period ending not earlier than the third anniversary of the date of the
      Award, except (A) for Performance Awards granted pursuant to, and
      governed by, Section 8 of the Plan, (B) for Awards, in the aggregate,
      for such number of shares of Common Stock not exceeding 5% of the
      available shares for Award under the Plan at the time of the Award, and
      (C) as otherwise specifically provided in the following subsections of
      this Section 7(d) of the
Plan.”

                

        

         

        3.           Section
7(d)(iv) of the Plan is deleted in its entirety and replaced as
follows:

         

        
          	
                                 
      “(iv)

                	
                  Except
      as otherwise determined by the Committee (other than to reduce the
      one-year period below), upon termination of a Participant’s employment or
      service with the Company during the Restriction Period by reason of the
      Participant’s Retirement, or the involuntary termination of the
      Participant’s employment or service by the Company without Cause occurring
      on or after the first anniversary

                

        

         

         

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

       

      
        
          	
                     

                	
                  of
      the date of the Award, a prorated portion of the shares of Restricted
      Stock under each such Award shall become unrestricted, and a prorated
      portion of the shares of Common Stock represented by Restricted Stock
      Units under each such Award shall become nonforfeitable and payable, with
      such proration to be based on the portion of the Restriction Period
      elapsed through the date of Retirement or involuntary termination, and for
      this purpose any performance objectives applicable to such Award shall be
      deemed satisfied at the target level of performance; as of Retirement or
      such involuntary termination, the remaining portion of such Award that
      does not become unrestricted or nonforfeitable pursuant to this Section
      7(d)(iv) shall be forfeited and
terminate.”

                

        

         

        4.           Section
8(f) of the Plan is deleted in its entirety and replaced as
follows:

         

        “(f)           Except
as otherwise determined by the Committee (other than to reduce the one-year
period below), if prior to the end of a Performance Period a Participant’s
employment or service with the Company terminates by reason of the Participant’s
involuntary termination of employment or service by the Company without Cause
occurring on or after the first anniversary of the date of the Award, the
Participant shall be entitled to an immediate prorated payment with respect to
each outstanding Performance Award, with such proration to be based on the
portion of the Performance Period elapsed through the date of involuntary
termination, and for this purpose the performance objectives applicable to such
Award shall be deemed satisfied at the target level of performance; as of such
involuntary termination, the portion of such Award which is not then payable
pursuant to this Section 8(f) shall be forfeited and terminate.”

         

        5.           The
Plan is hereby ratified, affirmed and continued, as amended hereby.

         

         

      

      
        
        

      

      
        2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]